American Journal of Nursing Research
ISSN (Print): 2378-5594 ISSN (Online): 2378-5586 Website: http://www.sciepub.com/journal/ajnr Editor-in-chief: Apply for this position
Open Access
Journal Browser
Go
American Journal of Nursing Research. 2018, 6(4), 137-146
DOI: 10.12691/ajnr-6-4-1
Open AccessArticle

Herpes Zoster Epidemiological Model's Program: Its Effects on Elderly patients and Their Family Caregivers

Aliaa Mohammed Othman El_afandy1, and Mayada Taha Mahmoud Sabea1

1Lecturers in Community Health Nursing Department, Faculty of Nursing, Helwan University, Egypt

Pub. Date: April 28, 2018

Cite this paper:
Aliaa Mohammed Othman El_afandy and Mayada Taha Mahmoud Sabea. Herpes Zoster Epidemiological Model's Program: Its Effects on Elderly patients and Their Family Caregivers. American Journal of Nursing Research. 2018; 6(4):137-146. doi: 10.12691/ajnr-6-4-1

Abstract

Herpes zoster strikes millions of older adults annually worldwide and disables a substantial number of them via postherpetic neuralgia. Aim: This study aimed to evaluate herpes zoster epidemiological model's program: Its effects on elderly patients and their family caregivers. Research design: A quasi-experimental design was used in this study. Setting: The study was conducted at the Out-patient Clinic of the Health Insurance Hospital in Helwan Distract. Subjects: A purposive sample was used to select 50 elderly patients and 50 of their family caregivers, who were included in this study. Tools: Used for data collection included an interviewing questioner, which consists of four parts: I. Socio-demographic characteristics of elderly patient and their family caregiver as age, gender, educational level, and occupation. II. Elderly patients and family caregiver's knowledge regarding herpes zoster as: meaning of the disease, causes, signs and symptoms, complications, and mode of transmission. III. An epidemiological model's information questionnaire that includes three aspects as; person, agent and environment. IV. Elderly patient's and family caregiver's practices regarding herpes zoster toward control and prevention as reported by them such as; patient isolation, using special equipment, using mask and gloves. Results: This study showed, statistically significant improvement of elderly patients' and family caregivers' knowledge, practices, and epidemiological model´s information regarding herpes zoster (3.66±2.401 to 7.70±4.0082, and 2.700±1.675 to 8.260±3.541) (4.140±4.646 to 8.600±2.777and 4.200± 4.458 to 9.240±1.559) (7.62±7.999 to 16.00±4.449 and 7.360±7.745 to 16.460±3.339) respectively post program implementation. Conclusion: Highly statistically significant effect on knowledge and practices of the elderly patients and family caregivers post epidemiological model's program. Recommendations: Dissemination of the epidemiological model for patients and family caregivers of herpes zoster during follow-up visits. An illustrated booklet should be provided with a description of disease control and prevention. Further researches are needed in other areas especially rural areas to estimate the effect of epidemiological model in disease prevention and control.

Keywords:
herpes zoster epidemiological model elderly patients family caregivers

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Franco, E., Gabutti, G., Bonanni, P., Conversano, M., Stefano, M.E., Ferro, A., Icardi, G., Antonio M.L., Maggi, S., Rossi, A., Scotti, S., Vitale, F., & Greco, D.: Herpes zoster and its prevention in Italy. Scientific consensus statement Ig Sanita Pubbl,; 70(1): 111-27, Jan-Feb 2014.
 
[2]  Kawai, K., Berhanu, G.G., & Camilo, J.A.: Systematic review of incidence and complications of herpes zoster: towards a global perspective; bmj Open.; 4(6): E004833, 2014.
 
[3]  Robert, W., Johnson, M.J., Alvarez-Pasquin, M.B., Elisabetta, F.J., Gaillat, João, G., Clara, M., Labetoulle, J.P., Michel, L.N., Luis, & Thomas, W.: Herpes zoster epidemiology, management, and disease and economic burden in Europe: A multidisciplinary perspective; Ther Adv Vaccines,; 3(4): 109-120, Jul 2016.
 
[4]  Bloch, K., & Johnson, J.: Varicella zoster virus transmission in the vaccine era: Unmasking the role of herpes zoster. J Infect Dis, 205: 1331-1333, 2014.
 
[5]  Harriet, J.F., Sara, L.T., & Sinéad, M.L.: The epidemiology and prevention of Herpes Zoster. Current Dermatology Reports, 1(1): 39-47, 2015.
 
[6]  CDC (2018): Shingles surveillance. Available at https://www.cdc.gov/shingles/surveillance.html.
 
[7]  Public Health Agency of Canada: Statement on seasonal influenza vaccine for 2014–2015. Canada: Public Health Agency of Canada, 2014.
 
[8]  WHO: Varicella and Herpes Zoster vaccines: WHO position paper, social determinants and public health programmes, available at: www.who.int/nmh/publications/ncd_report_chapter2.pdf, 2018.
 
[9]  Sampathkumar, P., Drage, L. A., & Martin, D.P.: Herpes zoster (Shingles) and postherpetic Neuralgia, Mayo Clin Proc.; 84(3): 274-280. 2014.
 
[10]  Chen, S.Y., Suaya, J.A., & Li, Q.,: Incidence of herpes zoster in patients with altered immune function. Infection; 42:325-34, 2014.
 
[11]  Cunningham, A.L., Breuer, J., Dwyer, D.E., Gronow, D.W., Helme, R.D., Litt, J.C., Levin, M.J. & MacIntyre, C.R.: The prevention and management of herpes zoster; Med J Aust; 188 (3): 171-176.
 
[12]  Rothman, K.J.: Causes, Am J Epidemiol; 104: 587-92, 1976.
 
[13]  CDC: Principle of epidemiology in public health practices, third edition: An introduction to applied epidemiology and biostatistics. available at www.cdc.org/ophss/csels/dsepd/ss1978, 2012.
 
[14]  Dawson, B.D., & Trapp, R.G.,: Reading the medical literature: Basic & Clinical Biostatistics.(3rd ed.). Newyork: Lange Medical Book/ McGraw–Hill. Medical Publication Division, Ch. 7-9, pp. 161-218 and Ch. 13, pp. 305-314, 2001.
 
[15]  Wiegering, V., Schick, J., Beer, M., Weissbrich, B., Gattenlohner, S., Girschick, H.J., Liese, J., Schlegel, P.G., Eyrich, M.: Varicella-zoster virus infections in immunocompromised patients - A single centre 6-years analysis. BMC, Pediatrics, 11: 31, 2013.
 
[16]  Mizukami, A., Sato, K., Adachi, K., Matthews, S., Holl, K., Matsuki, T., Kaise, T., & Curran, D.,: Impact of herpes zoster and post- herpetic neuralgia on health- related quality of life in japanese adults aged 60 years or older: Results from a prospective, observational cohort study, Clin Drug Investig.; 38(1): 29-37. Jan 2018.
 
[17]  Chayangsu, O., Jiamton, S., Leeyaphan, C., Prasertworonun, N., Omcharoen, V., & Kulthanan, K.: Willingness to pay, quality of life, and knowledge on herpes zoster among Thai patients prior zoster vaccine era. Southeast Asian J Trop Med Public Health, 47: 6, 2016.
 
[18]  Lee, T.J., CMD, M.D., Hayes, S., Doyle, M.C, Pharm, D., Lee, Y.W., Lew, B.L. & Sim, W.Y.: Awareness, knowledge, and vaccine Acceptability of Herpes Zoster in Korea: A Multicenter Survey of 607 Patients: Ann Dermatol, 27: 5, 2015.
 
[19]  Roh, N.K., Park, Y.M., Kang H., Choi, G.S., Kim, B.J., Lee, Y.W., Lew B.L., & Sim W.Y.: Awareness, knowledge, and vaccine acceptability of Herpes Zoster in Korea: A Multicenter survey of 607, patients, Ann Dermatol, 27: 5. 2015.
 
[20]  Aziz, M., Kessler, H., Huhn, G.: Providers' lack of knowledge about herpes zoster in HIV-infected patients is among barriers to herpes zoster vaccination. Int J STD AIDS,; 24(6):433-9, Jun 2013.
 
[21]  Miyachi, m., & Imafuku, S.: Relationship between prior knowledge about herpes zoster and the period from onset of the eruption to consultation in patients with herpes zoster. J Dermatol ; 43(10): 1184-1187, Oct 2016.
 
[22]  Lam, A.C., Chan, M.Y., Chou, H.Y., Ho, S.Y., Li, H.L., Lo, .Y., Shek, K.F., To, S.Y., Yam, K.K., & Yeung, I.: A cross-sectional study of the knowledge, attitude, and practice of patients aged 50 years or above towards herpes zoster in an out-patient setting. Hong Kong Med J.,: 23(4):365-73. Epub Aug 2017.
 
[23]  Yang, T.U., Cheong, H.J., Song, J.Y., Noh, J.Y., & Kim, W.J.: Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea. Human Vaccines & Immuno therapeutics 11(3):719-726, 2015.
 
[24]  Saba, J., Fatima, J., Rana, M.M. & Stephen, K.T.: Herpes zoster vaccine awareness among people ≥ 50 years of age and its implications on immunization. Dermatology Online Journal; 18 (8): 2, 2012.
 
[25]  Wang, J.D., Ford, L.J., Pharm, D., Wingate, L.M., Uroza, S.F., Jaber, N., Smith, C., Randolph, R., Lane, S ., & Foster, S. L.: The effect of pharmacist intervention on herpes zoster vaccination in community pharmacies .J Am Pharm Assoc. 1; 53(1): 46-53, Jan 2013.
 
[26]  Teeter, B.S., Garza, K.B., Stevenson, T.L., Williamson, M.A., Zeek, M.L., & Westrick, S.C.: Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies. Vaccine, 29; 32(43): 5749-54. Sep 2014.
 
[27]  Johnson, A.R., McElhaney, B.J., Pedalino, C.B., & Levin, D.M.: Prevention of herpes zoster and its painful and debilitating complications. International Journal of Infectious Diseases 11 (2); S43-S48, 2007.
 
[28]  Kimberly, B.P., Williamson, M., Stevenson, B.S., Benjamin, S.B., MSaMegan, L.T., & Salisa, C.Z.: Patient vaccination education program through an introductory pharmacy practice experience. Currents in Pharmacy Teaching and Learning, 7 (6), 764-770, November–December 2015.
 
[29]  Amirthalingam, G., Andrews, N., Keel, P., Mullett, D., Correa, A., de Lusignan, S., & Ramsay, M.: Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: A population-based study; The Lancet Public Health, 3 (2): e82-e90, February 2018.
 
[30]  Maung, Z.T., Taylor, P.R., Robinson, P.: Patient education for self-referral and on-demand treatment for herpes zoster in lymphoma patients. Leuk Lymphoma, 11: 447-452, 2009.
 
[31]  Ahrens,W., Krickeberg,K., & Pigeot, I.,: An Introduction to Epidemiology. In: Ahrens W., Pigeot I. (eds) Handbook of Epidemiology. Springer, Berlin, Heidelberg Available at: http://www.springer.com/978-3-540-00566-7, 2015.
 
[32]  Nganwa, D., Habtemariam, T., Tameru, B., Gerbi, G., Bogale, A., Robnett, V., & Wilson, W.: Applying the epidemiologic problem oriented approach (EPOA) methodology in developing a knowledge and practice base for the modeling of HIV/AIDS, S1-173-7, 2011.